Cognixion

Cognixion™ is a neurotech A.I. company building a commercially viable biosignal recognition system that moves neuroscience from the lab to market. The new artificial intelligence-powered signal processing platform translates brainwave signals via a BCI directly into communication. Cognixion is located in Toronto, Ontario and Santa Barbara, California, and builds technology solutions that elegantly blend the power of artificial intelligence (A.I.), neuroscience (BCI) and augmented reality (AR). Cognixion is internationally recognized for its innovation and use of exponential technologies to solve a social and healthcare global challenge - affecting the lives of 509 million people unable to speak. Cognixion has won the prestigious Roddenberry Prize, the Gold Edison Award for Social Impact, and the Singularity University Global Grand Challenge for Education for its potential to impact over a billion lives. For more information visit us at Cognixion.com.